Eversept Partners, LP Portfolio Holdings

Eversept Partners, LP

$904 Million
Q1 2025

Eversept Partners, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $904 Million distributed in 57 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $126M, Hca Healthcare, Inc. with a value of $52.7M, Syndax Pharmaceuticals Inc with a value of $51.8M, Vera Therapeutics, Inc. with a value of $45.6M, and Perkinelmer Inc with a value of $36.2M.

Examining the 13F form we can see an decrease of $86.5M in the current position value, from $991M to 904M.

Eversept Partners, LP is based out at New York, NY

Below you can find more details about Eversept Partners, LP portfolio as well as his latest detailed transactions.

Portfolio value $904 Million

Healthcare: $789 Million

ETFs: $112 Million

Basic Materials: $1.99 Million

Financial Services: $595,000

Stock Holdings Table

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
NAMS Newamsterdam Pharma CO Nv Shs	-	$0 0.0% of portfolio	-	Q1 2025 Added 2.03%
Fortrea Hldgs Inc	-	$0 0.0% of portfolio	-	Q1 2025 Reduced 27.0%
Karyopharm Therapeutics Inc	-	$0 0.0% of portfolio	-	Q1 2025 New
Zenas Biopharma Inc	-	$0 0.0% of portfolio	-	Q1 2025 Added 158.91%
Gsk PLC	-	$0 0.0% of portfolio	-	Q1 2025 Reduced 28.36%

Summary

Portfolio
No. of Stocks 57
Current Value $904 Million
Prior Value $991 Million
Filing
Period Q1 2025
Filing Date May 15, 2025
Form Type 13F-HR
Activity in Q1 2025
New Purchases 12 stocks
Additional Purchases 22 stocks
Sold out of 0 stocks
Reduced holdings in 20 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Portfolio Holdings